Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Life Science Invest Stockholm AB
AB
Active
Org 5592466691
Rörstrandsgatan 38, 113 40
Stockholm
Business and other management consultancy activities
· NACE 7020
Est. 2020
0 employees
Watchlist
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
Life Science Invest Stockholm AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
130
119
92
162
Staff expenses
—
—
—
—
—
EBITDA
−27
66
23
−33
−4
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−27
66
23
−33
−4
Net financials
—
—
—
—
−386
Profit before tax
−27
66
23
−33
−197
Tax
−0
−9
−8
−0
−0
Net profit
−27
57
15
−33
−197
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 001
1 291
992
928
726
Equity
138
195
210
170
25
Long-term debt
0
0
0
0
0
Short-term debt
864
1 096
782
758
701
Total debt
864
1 096
782
758
701
Financial ratios
5-year trend
EBITDA margin
-2.5%
This company
15.8%
Market median
-116% vs market
2020
2024
Equity ratio
3.4%
This company
38.2%
Market median
-91% vs market
2020
2024
Return on equity
-788.0%
This company
18.4%
Market median
-4383% vs market
2020
2024
Net profit margin
-121.6%
This company
8.1%
Market median
-1601% vs market
2020
2024
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
2020
2024
Debt / equity
28.04×
This company
0.62×
Market median
-4423% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-03-01 – 2020-12-31
View
PDF
More on Life Science Invest Stockholm AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
